Castle Biosciences, Inc. (CSTL)

Castle Biosciences Revenue

Castle Biosciences had revenue of $83.04M in the quarter ending September 30, 2025, a decrease of -3.19%. This brings the company's revenue in the last twelve months to $343.53M, up 10.15% year-over-year. In the year 2024, Castle Biosciences had annual revenue of $332.07M with 51.09% growth.

• Revenue (ttm): $343.53M
• Revenue Growth: +10.15%
• P/S Ratio: 2.73
• Revenue / Employee: $417,412
• Employees: 823
• Market Cap: 955.93M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	332.07M	112.28M	51.09%
Dec 31, 2023	219.79M	82.75M	60.38%
Dec 31, 2022	137.04M	42.95M	45.65%
Dec 31, 2021	94.09M	31.44M	50.18%
Dec 31, 2020	62.65M	10.78M	20.79%
Dec 31, 2019	51.87M	29.08M	127.62%
Dec 31, 2018	22.79M	9.03M	65.67%
Dec 31, 2017	13.75M	-	-